Model-Informed Dose Selection for Xentuzumab, a Dual Insulin-Like Growth Factor-I/II—Neutralizing Antibody

1. Parra-Guillen, Z.P.
2. Schmid, U.
3. Janda, A.
4. Freiwald, M.
5. Troconiz, I.F.